(HealthDay)—Among men with very-low-risk prostate cancer (PCa) who meet criteria for active surveillance but undergo radical prostatectomy, African-American race is associated with poorer outcomes, with higher rates of ...
Jun 18, 2013
0
0
Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
Jun 5, 2013
0
0
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
May 20, 2013
0
0
Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most ...
May 9, 2013
0
0
(HealthDay)—For people who have suffered from cellulitis of the leg, a long course of low-dose penicillin prevents the painful infection from returning, British researchers report.
May 2, 2013
0
0
A new discovery about the malaria-related parasite Toxoplasma gondii—which can threaten babies, AIDS patients, the elderly and others with weakened immune function—may help solve the mystery of how this single-celled ...
Apr 8, 2013
0
0
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results ...
Mar 4, 2013
0
0
Certain gene mutations affect individuals' risk of developing a serious kidney condition, as well as their prognosis after being diagnosed with the disease, according to a study appearing in an upcoming issue of the Journal ...
Feb 21, 2013
0
0
A process that normally occurs in developing embryos – the changing of one basic cell type into another – has also been suspected of playing a role in cancer metastasis. Now a study from Massachusetts General Hospital ...
Jan 31, 2013
0
0
Recent studies have demonstrated that molecular-targeted agents, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), may prolong survival of selected patients based on tumor biomarkers. The presence ...
Jan 15, 2013
0
0
